Precision Medicine & Digital Health Leader, Data scientist, Great boss award, Force multiplier, Service to America award, Startup & NonProfit Board Governance
Super excited about this panel with @TClozel @NCIJBSloan Jim Chen and @ihuerga at #BioIT22 next week. Join us in person or virtually to discuss how #AI is transforming #oncology R&D and care delivery. https://t.co/7zbZOpbKGJ
Leading experts discuss applications, pitfalls, and future directions for applications of AI in oncology in the AI for Oncology, Precision Medicine, and Health track @ Bio-IT this May! https://t.co/Bais8Cxdk1
#BioIT22@bioitworld#medicine#research#health#ai@subhamadhavan
Important features when evaluating a potentially oncogenic fusion like LMNA-NTRK1: ✅stranding and directionality ✅ kinase domain preserved ✅ in-frame https://t.co/nfvyEjj34T
Invited Speaker @subhamadhavan presented incredibly innovative work at #CGCAnnual2021 using #AI, #NLP, and expert crowdsourcing approaches to enable precision medicine, match patients to trials, automatically identify adverse events, and standardize curation of somatic variants.
Terrific graphic that highlights differences between lung and breast clinical communities in terms of uptake of precision medicines. #ASCO21’s theme of access to (right) care is clearly important.
Thought provoking graphic. I would say that despite initial (healthy) debate, most of us in the lung cancer space are recommending adjuvant osimertinib where available. #LCSM#ASCO21
@NCIDirector shares his opening remarks @ASCO#ASCO2021. Since 1990, there has been a 30% drop in cancer mortality due to behavior modifications like tobacco cessation and new/exciting drugs such as immunotherapies and targeted therapies.
Congratulations to @Georgetown_HIDS alumni Fuyuan Wang! He recently joined @FredNatLab subcontractor Essential Software as Software Engineer.
Apply to our one year industry driven #HealthInformatics & #DataScience Masters Program. Deadline July 1st: https://t.co/iMyirkC1dN
@DShaywitz@timmermanreport Terrific post and Happy Sunday! Love the characterization of bilingual experts in data science and medical science. Would be interesting to see what opportunities are being seized by these experts in subsequent TR column.